BioLife Solutions Inc.

24.79
0.44 (1.81%)
At close: Apr 24, 2025, 3:59 PM
24.80
0.04%
After-hours: Apr 24, 2025, 04:05 PM EDT
1.81%
Bid 21.76
Market Cap 1.18B
Revenue (ttm) 87.2M
Net Income (ttm) -20.18M
EPS (ttm) -0.25
PE Ratio (ttm) -99.16
Forward PE 168.85
Analyst Buy
Ask 29.89
Volume 351,330
Avg. Volume (20D) 438,100
Open 24.54
Previous Close 24.35
Day's Range 23.88 - 24.91
52-Week Range 16.10 - 29.55
Beta 1.93

About BLFS

BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor that are form...

Sector Healthcare
IPO Date Nov 22, 1989
Employees 159
Stock Exchange NASDAQ
Ticker Symbol BLFS
Full Company Profile

Analyst Forecast

According to 7 analyst ratings, the average rating for BLFS stock is "Buy." The 12-month stock price forecast is $31, which is an increase of 25.05% from the latest price.

Stock Forecasts

Next Earnings Release

BioLife Solutions Inc. is scheduled to release its earnings on May 8, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
11 months ago
+5.73%
BioLife Solutions shares are trading higher after ... Unlock content with Pro Subscription